PRP vs Betamethasone Upper Trapezius Myofascial Pain Study
Summary
ClinicalTrials.gov has registered a new randomized, Phase 4 clinical trial (NCT07547605) comparing platelet-rich plasma (PRP) injections against betamethasone for the treatment of myofascial pain syndrome affecting the upper trapezius muscle. The trial's structured record includes eligibility criteria, intervention details, and outcome measures. No recruitment status, enrollment figure, or anticipated completion date was provided in the registration entry.
About this source
GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
NIH's ClinicalTrials.gov has posted a new Phase 4 clinical trial registration (NCT07547605) for a randomized study comparing PRP injections to betamethasone for upper trapezius myofascial pain. The registration entry captures the study's title, condition (myofascial pain syndrome, upper trapezius), and intervention comparison (platelet-rich plasma vs. betamethasone). The record is structured per FDAAA 801 requirements for applicable clinical trials.
Affected parties — clinical investigators, trial sponsors, and referring clinicians — should note the trial's existence for patient-referral and competitive-landscape awareness. This is an informational registration event; it does not itself impose compliance obligations beyond standard FDAAA 801 trial-registration obligations that already apply to the sponsoring entity.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 4 Trials
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.